Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Jafi Multia Oy
OY
Dissolved
Y-tunnus 0975703-4
Nummenpääntie 533, 01860
Perttula
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 1993 · 32 years old
— employees
Share
Finland
/
Companies
/
Manufacture of pharmaceutical preparations
/
Jafi Multia Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2024
0M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2020
2021
2022
2024
2025
Revenue
1
7
18
3
0
Staff expenses
—
—
—
—
—
EBITDA
−3
2
−1
6
2
Depreciation & amort.
—
—
—
—
—
EBIT
−3
2
−1
0
−2
Net financials
2
2
3
2
−3
Profit before tax
−1
4
2
−8
−16
Tax
−0
−0
−0
1
−0
Net profit
−1
4
2
−9
−16
Balance sheet
EUR thousands
Item
2020
2021
2022
2024
2025
Total assets
67
69
70
59
44
Equity
46
50
52
56
40
Long-term debt
—
—
—
—
—
Short-term debt
21
19
18
3
4
Total debt
21
19
18
3
4
Financial ratios
5-year trend
EBITDA margin
247800.0%
This company
15.8%
Market median
+1568254% vs market
2020
2025
Equity ratio
90.3%
This company
38.2%
Market median
+136% vs market
2020
2025
Return on equity
-41.4%
This company
18.4%
Market median
-325% vs market
2020
2025
Net profit margin
-1640400.0%
This company
8.1%
Market median
-20251952% vs market
2020
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
2020
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-02-01 – 2025-01-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-02-01 – 2024-01-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-02-01 – 2022-01-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-02-01 – 2021-01-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2019-02-01 – 2020-01-31
View
PDF
More on Jafi Multia Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
